Amag Pharmaceuticals

AMAG CMO hits the exit just as biotech searches for new CEO to right a ship rocked by Makena controversy
AMAG CMO hits the exit just as biotech searches for new CEO to right a ship rocked by Makena controversy
Endpoints
Amag Pharmaceuticals
Makena
Flag link:
Call for FDA to withdraw preterm birth drug divides doctors and insurers
Call for FDA to withdraw preterm birth drug divides doctors and insurers
Fierce Pharma
pre-term birth
Makena
physicians
insurers
FDA
Amag Pharmaceuticals
Flag link:
Amag CEO to step down as troubled pharma looks to sell 2 drugs
Amag CEO to step down as troubled pharma looks to sell 2 drugs
BioPharma Dive
Amag Pharmaceuticals
restructuring
Vyleesi
Intrarosa
William Heiden
Flag link:
FDA Ad Com thumbs down on full Makena approval
FDA Ad Com thumbs down on full Makena approval
Seeking Alpha
Makena
preterm birth
Amag Pharmaceuticals
FDA
advisory panels
Flag link:
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Yahoo/Benzinga
Adamis Pharmaceuticals
Redhill Biopharma
Amag Pharmaceuticals
Arqule
Agile Therapeutics
Agios Pharmaceuticals
Deciphera
Mirati Therapeutics
Sutro BioPharma
Merck
Pfizer
Amgen
EXACT Sciences
Bristol-Myers Squibb
Celgene
Oyster Point Pharma
Flag link:
Public Citizen urges FDA to ‘immediately’ withdraw drug for preventing premature birth
Public Citizen urges FDA to ‘immediately’ withdraw drug for preventing premature birth
Stat
Makena
premature birth
Amag Pharmaceuticals
FDA
citizen petitions
Public Citizen
Flag link:
FDA review of troubled drug could hobble AMAG in proxy fight with activist investor
FDA review of troubled drug could hobble AMAG in proxy fight with activist investor
Fierce Pharma
Amag Pharmaceuticals
shareholders
FDA
Makena
Flag link:
Why This New FDA-approved Drug Vyleesi Is Not 'Female Viagra'
Why This New FDA-approved Drug Vyleesi Is Not 'Female Viagra'
Forbes
Vyleesi
female sexual dysfunction
HSDD
Amag Pharmaceuticals
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Merck
Keytruda
Melinta Therapeutics
Amag Pharmaceuticals
Palatin
Acer Therapeutics
Sanofi
Regeneron
Alexion
Pfizer
Roche
Navidea Biopharmaceuticals
Ascendis Pharma
Scholar Rock
Adaptive Biotechnologies
BridgeBio
IPOs
G Medical Innovations
Karuna
Morphic Therapeutics
Flag link:
Is sexual desire a medical issue? An experimental drug for women revives an intense debate
Is sexual desire a medical issue? An experimental drug for women revives an intense debate
Stat
FDA
female sexual dysfunction
bremelanotide
HSDD
Amag Pharmaceuticals
Flag link:
3 Drug Stocks That Could Win From Key FDA Approvals in June
3 Drug Stocks That Could Win From Key FDA Approvals in June
Motley Fool
Merck
Amag Pharmaceuticals
Alexion Pharma
FDA
Keytruda
Vyleesi
Soliris
Flag link:
Mark Your Calendar For These June PDUFA Dates
Mark Your Calendar For These June PDUFA Dates
Yahoo/Benzinga
FDA
Merck
Zerbaxa
XERIS
Gvoke HypoPen
Keytruda
Amag Pharmaceuticals
Palatin
Vyleesi
Acer Therapeutics
Edsivo
Sanofi
Regeneron
Dupixent
Alexion
Soliris
Retrophin
Thiola
Allergan
Botox
Flag link:
Years after it was OK'd, AMAG's drug for preventing preterm births fails badly in long-awaited confirmatory trial
Years after it was OK'd, AMAG's drug for preventing preterm births fails badly in long-awaited confirmatory trial
Endpoints
Amag Pharmaceuticals
Makena
preterm birth
FDA
Flag link:
Amag's in-house digital revamp puts its consumer tactics to work in pharma
Amag's in-house digital revamp puts its consumer tactics to work in pharma
Fierce Pharma
Amag Pharmaceuticals
digital pharma
consumers
Flag link:
AMAG to hire 150 new sales reps to tout newly licensed women's health med Intarosa
AMAG to hire 150 new sales reps to tout newly licensed women's health med Intarosa
Fierce Pharma
Amag Pharmaceuticals
Women's Health
hirings
drug reps
Intarosa
vaginal pain
Flag link:
With new additions, PhRMA opens door to generics drugmaker Teva
With new additions, PhRMA opens door to generics drugmaker Teva
BioPharma Dive
PhRMA
generics
Teva Pharmaceuticals
Alexion
Amag Pharmaceuticals
Horizon Pharma
Jazz Pharmaceuticals
Flag link:
4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming
4 Biopharma and Pharmaceutical Stocks With Game-Changing Catalysts Coming
24/7 Wall St
Pfizer
Sarepta Therapeutics
PTC Therapeutics
Amag Pharmaceuticals
Flag link:
AMAG buying Cord Blood Registries for $700 million
AMAG buying Cord Blood Registries for $700 million
Yahoo/AP
Amag Pharmaceuticals
M&A
Cord Blood Registries
Flag link:
Meet 5 Top Drug Stocks That Are Bolting Past Market
Meet 5 Top Drug Stocks That Are Bolting Past Market
Investors.com
Celgene
Amgen
AstraZeneca
Hospira
Amag Pharmaceuticals
Flag link:
Amag Pharma buys women's health company Lumara for $675 mln
Amag Pharma buys women's health company Lumara for $675 mln
Yahoo/Reuters
Amag Pharmaceuticals
M&A
Lumara
Women's Health
Flag link:

Pages